Neuronetics (STIM) Other Non-Current Liabilities (2017 - 2026)

Neuronetics' (STIM) quarterly Other Non-Current Liabilities came in at $71000.0 in Q1 2026, down 96.25% on a QoQ basis from $1.9 million in Q2 2018.

Neuronetics (STIM) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Neuronetics (STIM) has 3 years of Other Non-Current Liabilities data on file, last reported at $71000.0 in Q1 2026.

On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $71000.0 in Q1 2026; TTM through Mar 2026 was $71000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $478000.0, changed N/A from the prior year.
Other Non-Current Liabilities for Q1 2026 stood at $71000.0, down from $1.9 million in the prior quarter.
Over the last five years, Other Non-Current Liabilities for STIM reached as high as $71000.0 in Q1 2026 and fell as low as $71000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Neuronetics	130.83 Mn	128.62 Mn	16.15 Mn

Download Data